GSA Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-518
| Closed | -$216K | – | 1477 |
|
2022
Q3 | $216K | Buy |
+518
| New | +$216K | 0.03% | 1172 |
|
2022
Q1 | – | Sell |
-498
| Closed | -$376K | – | 1412 |
|
2021
Q4 | $376K | Buy |
+498
| New | +$376K | 0.05% | 786 |
|
2020
Q3 | – | Sell |
-824
| Closed | -$372K | – | 1245 |
|
2020
Q2 | $372K | Buy |
+824
| New | +$372K | 0.21% | 123 |
|
2019
Q4 | – | Sell |
-1,907
| Closed | -$635K | – | 1433 |
|
2019
Q3 | $635K | Buy |
+1,907
| New | +$635K | 0.09% | 404 |
|
2018
Q4 | – | Sell |
-3,568
| Closed | -$1.12M | – | 1358 |
|
2018
Q3 | $1.12M | Sell |
3,568
-225
| -6% | -$70.4K | 0.06% | 614 |
|
2018
Q2 | $1.09M | Buy |
3,793
+1,747
| +85% | +$504K | 0.05% | 701 |
|
2018
Q1 | $512K | Sell |
2,046
-1,826
| -47% | -$457K | 0.03% | 1047 |
|
2017
Q4 | $924K | Buy |
+3,872
| New | +$924K | 0.06% | 630 |
|
2017
Q3 | – | Sell |
-1,314
| Closed | -$297K | – | 1604 |
|
2017
Q2 | $297K | Buy |
+1,314
| New | +$297K | 0.02% | 1281 |
|
2016
Q3 | – | Sell |
-2,590
| Closed | -$370K | – | 1770 |
|
2016
Q2 | $370K | Buy |
+2,590
| New | +$370K | 0.02% | 1266 |
|
2016
Q1 | – | Sell |
-6,390
| Closed | -$886K | – | 1673 |
|
2015
Q4 | $886K | Sell |
6,390
-112
| -2% | -$15.5K | 0.04% | 788 |
|
2015
Q3 | $873K | Buy |
6,502
+4,503
| +225% | +$605K | 0.04% | 750 |
|
2015
Q2 | $301K | Sell |
1,999
-5,801
| -74% | -$873K | 0.01% | 1612 |
|
2015
Q1 | $1.05M | Buy |
7,800
+1,700
| +28% | +$230K | 0.04% | 824 |
|
2014
Q4 | $735K | Buy |
+6,100
| New | +$735K | 0.05% | 676 |
|
2014
Q1 | – | Sell |
-3,200
| Closed | -$396K | – | 1560 |
|
2013
Q4 | $396K | Sell |
3,200
-200
| -6% | -$24.8K | 0.03% | 1009 |
|
2013
Q3 | $400K | Buy |
3,400
+1,500
| +79% | +$176K | 0.03% | 936 |
|
2013
Q2 | $213K | Buy |
+1,900
| New | +$213K | 0.03% | 1056 |
|